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Abstract Four exons of a human homologue of a yeast cell 
division cycle gene (MCM6/mis5, which is thought to encode a 
DNA replication licensing factor) have been identified 3.3 kb 
upstream from the start of transcription of the intestinal actase 
gene on human chromosome 2q21, initially by similarity to a rat 
'intestinal crypt-cell replication factor'. RT-PCR analysis shows, 
that unlike lactase, MCM6 is not restricted in its tissue 
distribution and does not show person-to-person variation in 
the level of expression in adult intestine. 
Key words: Lactase; MCM6;  Human intestine; 
Gene expression; DNA replication 
I. Introduction 
In the course of our efforts to identify the cis-acting element 
which causes the lactase persistence polymorphism in adult 
humans [1], we have been sequencing upstream of the start 
of transcription of the lactase gene (LCT). This paper is con- 
cerned with the identification of a novel gene in close proxi- 
mity to LCT, which has a high level of identity to a rat 
intestinal crypt-cell replication factor [2]. Both the human 
and rat genes appear to be mammalian homologues of a yeast 
cell division cycle gene identified as mis5 (in Schizosaccharo- 
myces pombe), more recently named MCM6 [3,4]. 
MCM6 is one of a large group of genes which were first 
identified in yeast by the analysis of temperature-sensitive 
mutants, which are either blocked at some point in the cell 
cycle (cdc) or unable to maintain the presence of mini-chro- 
mosomes (MCM). The genes were separated into groups or 
families depending on where the arrest occurs. MCM6 falls 
into the group (MCM2-7 [3,4]) in which the arrest occurs 
before S-phase. The protein products appear to play a role 
in 'licensing' the replication of DNA [5,6] and are thought to 
bind to DNA after mitosis (G1) and to be removed from the 
DNA during replication (S phase). They demonstrate a 200 
amino acid region of high similarity, which resembles DNA-  
dependent ATP-binding domains [7]. 
Identification of homologues of these genes in man is of 
great interest since they may play a role in cellular differentia- 
tion. Several of these genes have been identified in vertebrate 
DNA and homologues have so far been identified for MCM2 
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(BM28 [8]), MCM3 (P1 [9]), MCM4 (CDC54/cdc21 [10]), 
MCM5 (CDC46 [10]), and MCM7 (cdc47 [10]). A human 
MCM6 homologue has not so far been reported. 
2. Materials and methods 
2.1. Subcloning 
The lambda clone hchrlac7 has been reported previously [11]. This 
clone was sequentially digested by EcoRI and HindIII using the con- 
ditions recommended by the manufacturer (BRL). The resulting frag- 
ments were subcloned into pGEM-3Z (Promega) which had been 
digested with both EcoRI and HindlII. Clones with the correct insert 
sizes were chosen for further analysis. Three subclones were obtained: 
plc7, insert size 1.2 kb; plc9, insert size 1.8 kb and plcl, insert size 
approx. 9 kb. Representative colonies of each clone were grown and 
DNA prepared using a Wizard kit (Promega). 
2.2. PCR products for sequencing 
PCR products over 1 kb in length were made to cover the gaps 
remaining from the subcloning approach. The primer sequences are 
available on request. The amplification was performed in 100 ktl vo- 
lume and using standard conditions [12]. Taq polymerase was ob- 
tained from Advanced Biotechnologies or Promega nd amplification 
performed in a Hybaid Omnigene apparatus. Products were cleaned 
using a 4B Sepharose column (Pharmacia) and the resulting column 
fraction was used directly as sequencing template [13]. 
2.3. Sequencing 
Sequencing of clones was performed using Sequenase v2.0 (US 
Biochemicals) using double-stranded templates as described [14]. 
PCR products were initially boiled with primers and buffer for 5 
min and then snap cooled on dry ice and ethanol. The primers used 
were either from vector sequence or designed to 'walk' out from new 
sequence. 
2.4. Sequence analysis 
The GENBANK and EMBL databases were searched using the 
BLAST program and additional comparisons were made using FAS- 
TA, Wordsearch, Bestfit, Gap and Pileup, all parts of the GCG pack- 
age (University of Wisconsin) at the HGMP-RC computing centre. 
Both protein translations and nucleotide sequences were used in 
searches and comparisons. 
2.5. RNA samples and RT-PCR analysis 
The human tissues were as described previously [1,15-17]. Semi- 
quantitative RT-PCR was performed using the method escribed pre- 
viously [15] except hat the RT was performed at 37°C using 1 Ixg 
total RNA as starting material for 10 PCR reactions and, for MCM6 
only, 30 rounds of amplification (which gave a linear dose response 
for this transcript). Primer sequences for dipeptidylpeptidase IV 
(DPP4) and lactase-phlorizin hydrolase (LCT) were as described pre- 
viously. The primers for the MCM6 transcript were ZA1S and 4XA 
(see Table 1). Controls included the omission of reverse transcriptase, 
no template blanks and test amplifications of human genomic DNA. 
All rights reserved. 
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Fig. 1. Diagrammatic representation f the lambda hchrlac7 clone showing the positions of the MCM6 exons and LCT exonl in relation to 
the EcoRI (E) and HindlII (H) sites, and to the plcl, 7 and 9 subclones and the PCR products covering the region. The previously published 
sequence [11,12,18] was obtained from more than five different individuals. 
3. Results and discussion 
3.1. Identification of novel exons upstream from the lactase 
gene 
The human genomic clone (lambda hchrlac7) contains 15 
kb of insert sequence and includes the first exon and part of 
the first intron of the lactase gene [11]. 1 kb of sequence up- 
stream of the start of transcription has been published [18]. 
To characterise the remainder of the clone, three EcoRI/Hin- 
dIII subclones were partially sequenced, initially using vector 
primers and then further primers made to 'walk' along the 
sequence. Gaps not covered by the subclones were sequenced 
using a PCR-based strategy. Fig. 1 shows the positions of the 
subclones and the PCR products equenced. 
As they were obtained, sequences were used to search the 
databases. A novel exon (W) was identified through a short 
region of similarity to a rat intestinal crypt-cell replication 
factor (U17656) [2] and was shown to be 136 bp in length. 
Exons X (156 bp) and Y (140 bp) of the same transcript were 
identified by direct comparison of new sequence with the rat 
sequence. 
The positions of each of these exons are shown in the map 
in Fig. 1. 
3.2. Construction of a composite cDNA from EST sequences 
A derived composite cDNA sequence was made by joining 
together the W, X and Y exon sequences and this was used to 
screen the databases, including the EST (expressed sequence 
tags) databases. The databases were also screened using the 
rat (U17565) and S. pombe (mis5, D31960) sequences (see 
below). The overlapping EST sequences identified formed a 
cDNA contig spanning 1265 bp and contained the three exons 
already identified in genomic DNA (Fig. 2). 
The most 3' exon (Z) of the transcript was localised in the 
genomic subclone plcl by PCR using primers taken from the 
composite human cDNA sequence together with primers from 
sequence from the subclone itselfi The exon was sequenced 
using these PCR products as template. This exon is 509 bp 
in length and includes the 3'UTR and polyadenylation signal. 
Its position is shown in Fig. 1. Exon W is the most 5' exon 
present in the genomic lone. 
The composite human cDNA sequence shows 99.5% iden- 
tity (within the high-quality sequence ranges of the ESTs) to 
the genomic exons, right up to the start of the poly(A) tail. 
Very recently, two complete human cDNA sequences have 
appeared on the databases [19,20] and these both also show 
99% identity to the sequences reported here. 
3.3. Sequencing of the exon/intron boundaries 
By comparison of the genomic and cDNA sequences it was 
possible to identify the intron/exon boundaries of all four 
exons. In each case, further sequencing primers were designed 
as necessary such that the complete xon and the exon/intron 
boundaries at either side were sequenced on both strands: 
these sequences will be available on the databases (U67281- 
4). Table 1 lists the intron primers used to amplify and/or 
sequence across the exons. Classical ag/gt splice sites were 
identified at the ends of each exon. 
3.4. Sequence comparison with members of the MCM2-7 fa- 
mily 
Since the rat intestinal crypt-cell replication factor identified 
by Sykes and Weiser [2] had been shown to have a high level 
of similarity to the cdc/MCM family of proteins, the compo- 
site human cDNA sequence and the derived protein sequence 
were used to investigate the relationship of this transcript to 
the MCM gene family. These analyses howed that both of 
these sequences are most similar to the mis5 gene of S. pombe 
[21] (Fig. 3), the conclusion also reached by Tsugura and 
colleagues who recently submitted their sequence to the data- 
bases [19]. The name MCM6 has been suggested for these 
sequences [3,4]. Thus, the human gene described in this paper 
is designated MCM6 (HUGO/GDB approved gene symbol). 
3.5. Chromosomal location 
The clone lambda hchrlac7 had previously been used for the 
chromosomal mapping of the lactase gene and gave only one 
signal in fluorescence in situ hybridisation experiments [22], 
thus mapping MCM6 to 2q21. A PCR approach was used to 
confirm the disposition of the MCM6 exons and their close 
proximity to LCT in human genomic DNA in vivo. PCR 
amplification of genomic DNA performed in overlapping seg- 
ments across the whole region gave the expected size products 
(Fig. 1). In addition, a primer in the 3' exon (within the 3' 
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Fig. 2. Map of the contig made from EST sequences. The ESTs are identified by their Genbank/EMBL accession umbers. N.B. the sequences 
H67765/6 and T81375/6 are from opposite nds of the same clones. The nucleotide positions are numbered from one of the human cDNAs [20] 
which has recently appeared on the databases. The exon boundaries are indicated. 
UTR)  used together with a primer 200 bases upstream from 
the previously characterised lactase promoter sequence 
[12,18], produced the same 2.4 kb band both in the clone 
DNA and in 5 different genomic DNA samples (2 lactase 
persistent, 2 non-persistent and a known heterozygote). 
Other homologues of the MCM2-7 genes have been 
mapped in humans, MCM7 (p85MCM, CDCL1) to 7q21 
[23] and MCM3 has been mapped using the murine homolo- 
gue as probe, to 6p21 [24]. Thus, these genes are dispersed in 
the human genome as they are in the genome of S. cerevisiae 
(SacchDB). 
3.6. MCM6 expression in human tissues 
We estimate that the start of transcription of LCT is 3.3 kb 
from the end of MCM6. It seems probable that there are 
elements involved in the developmental nd tissue-specific ex- 
pression of LCT upstream from the immediate promotor but 
whether or not they overlap with MCM6 remains to be de- 
termined. The fact that MCM6 was reported to be expressed 
in intestine in the rat while lactase itself is expressed specifi- 
cally in the intestine was interesting. However, the clones con- 
taining the ESTs were derived from a variety of cDNA li- 
braries from different tissues and included adult breast, 
female placenta, fetal heart, and mixed fetal liver and spleen, 
suggesting that this sequence is expressed in a wide variety of 
tissues other than intestine. 
In order to explore the pattern of expression further and to 
compare with the pattern of lactase expression we performed 
RT-PCR experiments. Primers designed to amplify the 
MCM6 transcript were taken from separate xons such that 
a different sized product would be amplified from genomic 
DNA from that obtained from cDNA. Two different pairs 
of primers (5XS located in the next exon upstream, exon V, 
and taken from the rat sequence, together with 3UXA in exon 
Z; and ZA1S in exon X together with 4XA in exon Z, Table 
1) were shown to amplify cDNA from fetal intestine to pro- 
duce products of predicted size, confirming that these se- 
quences are part of an expressed gene. One pair (ZA1S and 
4XA) was selected to examine the tissue distribution. Lactase 
(LCT) and dipeptidyl peptidase IV primers were used on the 
same cDNAs. Examples of the results are shown in Fig. 4. 
The MCM6 transcript was expressed in all the tissues exam- 
ined in both fetuses and adults. From adults these were: liver, 
small intestine (n=4), colon (n=4), skeletal muscle, heart mus- 
cle and lung. From fetuses these were: liver, small intestine 
(n=7), colon (n=2), skeletal and limb muscle, stomach, pan- 
creas, kidney, spleen, and brain. We also tested term placenta. 
In general, a lower level of transcript was observed in adult 
Table 1 
Exon primers used for RT-PCR and intron primers used for sequencing and/or PCR of the exons 
Primer name Location Comments Sequence 
5XS exon V sense (rat) RT-PCR 5' gca ctg ctg tga tga gg 3' 
3UXA exon Z antisense RT-PCR 5' cac agt tcc tca gct ctg g 3' 
ZA1S exon X sense RT-PCR 5' gag tac tgc cga atc tct acc 3' 
4XA exon Z antisense RT-PCR 5' cac tgg agc ctt tca gtc c 3' 
7AS intron V sense forward through exon W 5' cta ctg tga ttt cat tgg gag 3' 
9Z2S intron W antisense back through exon W 5' caa cag cag gtg tac ttc tac 3' 
ZA3S intron W sense forward through exon X 5' gta aat gct tga caa ggg 3' 
ZA1A intron X antisense back through exon X 5' tag gct ggc agg tat gct g 3' 
RQ2 intron X sense forward through exon Y 5' ctg aca gta cga gtt gct ag 3' 
1AS intron Y antisense back through exon Y 5' ggt gac agc agt acg acc aag 3' 
5ZXS intron Y sense forward through exon Z 5' ggt cag cat cct act agg 3' 
3ZXA intron Z antisense back through exon Z 5' cca cag ttc tac ctc ttc tc 3' 
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Fig. 3. Comparison of the deduced amino-acid sequence of the MCM6 contig (hsapiens) and other MCM transcripts (from the rat (rnorveg): 
accession no. U17565; from C. elegans: accession no. P34647; from S. pombe: accession no. D31960). 
tissues than in fetal tissues. Small intestine samples from 7 
children (age range 0-8 years) were also tested. The level of 
MCM6 transcript in the small intestine of children was com- 
parable to that of the adults, both children and adults show- 
ing a lower level of expression than the fetuses. This pattern 
of expression contrasts with that of lactase which shows a 
very restricted distribution, occurring at detectable levels 
only in the intestine, and at high levels only in the small 
intestine of children and lactase persistent adults [15,17] 
(Fig. 4). 
We also explored the possibility that the level of expression 
of MCM6 in adult intestine might show person-to-person 
variation as observed for the lactase polymorphism. We 
thus examined lactase and MCM6 mRNA levels in adult 
small intestine from 10 different individuals of known lactase 
persistence status (5 lactase persistent and 5 non-persistent). 
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There was no apparent correlation in the levels of the MCM6 
and lactase transcripts. 
These results thus suggest that there are no functionally 
significant tissue specificity or developmental cis-acting ele- 
ments shared by the two genes. There can, however, be over- 
lap of the regulatory regions of one sequence with the end of 
another transcript over substantial distances. For example, a 
critical cis-acting tissue specific element for the c~-globin clus- 
ter is located within intron 5 of the so-called ' -14 '  gene tran- 
script at 40 kb from the start of transcription of the ~ gene 
[25]. Interestingly, the -14  gene, like MCM6, shows ubiqui- 
tous expression. 
The role of MCM6 in vertebrate cells is not known. It is 
tempting to speculate that in higher organisms it could play a 
role in terminal differentiation as well as licensing DNA re- 
plication. It is noteworthy that the transcript is expressed at 
relatively high levels both in tissues which contain many pro- 
liferating cells, such as testis and intestine, and in tissues 
where there is less proliferation such as muscle. Studies are 
in progress to determine whether, as reported in the rat, the 
transcript is more abundant in the dividing intestinal crypt 
cells than in the differentiated cells of the villi. 
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